ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amphotericin B for Injection Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-15F17167
Home | Market Reports | Health| Health Conditions
Global Amphotericin B for Injection Market Research Report 2024
BUY CHAPTERS

Global Amphotericin B for Injection Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-15F17167
Report
November 2025
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
North China Pharmaceutical
Cspc Holdings
Jemincare
SPH New Asia Pharmaceuticals

Amphotericin B for Injection Market

The global Amphotericin B for Injection market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Amphotericin B for Injection leading manufacturers including Gilead Sciences, SPH New Asia Pharmaceuticals, North China Pharmaceutical, Cspc Holdings, Jemincare, etc., dominate supply; the top five capture approximately % of global revenue, with Gilead Sciences leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Amphotericin B for Injection market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Amphotericin B for Injection Market Report

Report Metric Details
Report Name Amphotericin B for Injection Market
Segment by Type
  • Common Formulation
  • Liposome Formulation
Segment by Application
  • Hospital
  • Clinic
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Gilead Sciences, SPH New Asia Pharmaceuticals, North China Pharmaceutical, Cspc Holdings, Jemincare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Amphotericin B for Injection study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Amphotericin B for Injection Market report?

Ans: The main players in the Amphotericin B for Injection Market are Gilead Sciences, SPH New Asia Pharmaceuticals, North China Pharmaceutical, Cspc Holdings, Jemincare

What are the Application segmentation covered in the Amphotericin B for Injection Market report?

Ans: The Applications covered in the Amphotericin B for Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Amphotericin B for Injection Market report?

Ans: The Types covered in the Amphotericin B for Injection Market report are Common Formulation, Liposome Formulation

1 Study Coverage
1.1 Introduction to Amphotericin B for Injection: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Amphotericin B for Injection Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Common Formulation
1.2.3 Liposome Formulation
1.3 Market Segmentation by Application
1.3.1 Global Amphotericin B for Injection Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Amphotericin B for Injection Revenue Estimates and Forecasts 2020-2031
2.2 Global Amphotericin B for Injection Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Amphotericin B for Injection Sales Estimates and Forecasts 2020-2031
2.4 Global Amphotericin B for Injection Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Amphotericin B for Injection Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Amphotericin B for Injection Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Common Formulation Market Size by Manufacturers
3.5.2 Liposome Formulation Market Size by Manufacturers
3.6 Global Amphotericin B for Injection Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Amphotericin B for Injection Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Amphotericin B for Injection Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Amphotericin B for Injection Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Amphotericin B for Injection Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Amphotericin B for Injection Sales and Revenue by Type (2020-2031)
6.4 North America Amphotericin B for Injection Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Amphotericin B for Injection Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Amphotericin B for Injection Sales and Revenue by Type (2020-2031)
7.4 Europe Amphotericin B for Injection Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Amphotericin B for Injection Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Amphotericin B for Injection Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Amphotericin B for Injection Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Amphotericin B for Injection Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Amphotericin B for Injection Sales and Revenue by Type (2020-2031)
9.4 Central and South America Amphotericin B for Injection Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Amphotericin B for Injection Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Amphotericin B for Injection Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Amphotericin B for Injection Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Amphotericin B for Injection Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Gilead Sciences
11.1.1 Gilead Sciences Corporation Information
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Amphotericin B for Injection Product Models, Descriptions and Specifications
11.1.4 Gilead Sciences Amphotericin B for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Gilead Sciences Amphotericin B for Injection Sales by Product in 2024
11.1.6 Gilead Sciences Amphotericin B for Injection Sales by Application in 2024
11.1.7 Gilead Sciences Amphotericin B for Injection Sales by Geographic Area in 2024
11.1.8 Gilead Sciences Amphotericin B for Injection SWOT Analysis
11.1.9 Gilead Sciences Recent Developments
11.2 SPH New Asia Pharmaceuticals
11.2.1 SPH New Asia Pharmaceuticals Corporation Information
11.2.2 SPH New Asia Pharmaceuticals Business Overview
11.2.3 SPH New Asia Pharmaceuticals Amphotericin B for Injection Product Models, Descriptions and Specifications
11.2.4 SPH New Asia Pharmaceuticals Amphotericin B for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 SPH New Asia Pharmaceuticals Amphotericin B for Injection Sales by Product in 2024
11.2.6 SPH New Asia Pharmaceuticals Amphotericin B for Injection Sales by Application in 2024
11.2.7 SPH New Asia Pharmaceuticals Amphotericin B for Injection Sales by Geographic Area in 2024
11.2.8 SPH New Asia Pharmaceuticals Amphotericin B for Injection SWOT Analysis
11.2.9 SPH New Asia Pharmaceuticals Recent Developments
11.3 North China Pharmaceutical
11.3.1 North China Pharmaceutical Corporation Information
11.3.2 North China Pharmaceutical Business Overview
11.3.3 North China Pharmaceutical Amphotericin B for Injection Product Models, Descriptions and Specifications
11.3.4 North China Pharmaceutical Amphotericin B for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 North China Pharmaceutical Amphotericin B for Injection Sales by Product in 2024
11.3.6 North China Pharmaceutical Amphotericin B for Injection Sales by Application in 2024
11.3.7 North China Pharmaceutical Amphotericin B for Injection Sales by Geographic Area in 2024
11.3.8 North China Pharmaceutical Amphotericin B for Injection SWOT Analysis
11.3.9 North China Pharmaceutical Recent Developments
11.4 Cspc Holdings
11.4.1 Cspc Holdings Corporation Information
11.4.2 Cspc Holdings Business Overview
11.4.3 Cspc Holdings Amphotericin B for Injection Product Models, Descriptions and Specifications
11.4.4 Cspc Holdings Amphotericin B for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Cspc Holdings Amphotericin B for Injection Sales by Product in 2024
11.4.6 Cspc Holdings Amphotericin B for Injection Sales by Application in 2024
11.4.7 Cspc Holdings Amphotericin B for Injection Sales by Geographic Area in 2024
11.4.8 Cspc Holdings Amphotericin B for Injection SWOT Analysis
11.4.9 Cspc Holdings Recent Developments
11.5 Jemincare
11.5.1 Jemincare Corporation Information
11.5.2 Jemincare Business Overview
11.5.3 Jemincare Amphotericin B for Injection Product Models, Descriptions and Specifications
11.5.4 Jemincare Amphotericin B for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Jemincare Amphotericin B for Injection Sales by Product in 2024
11.5.6 Jemincare Amphotericin B for Injection Sales by Application in 2024
11.5.7 Jemincare Amphotericin B for Injection Sales by Geographic Area in 2024
11.5.8 Jemincare Amphotericin B for Injection SWOT Analysis
11.5.9 Jemincare Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Amphotericin B for Injection Industry Chain
12.2 Amphotericin B for Injection Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Amphotericin B for Injection Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Amphotericin B for Injection Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Amphotericin B for Injection Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Amphotericin B for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
North China Pharmaceutical
Cspc Holdings
Jemincare
SPH New Asia Pharmaceuticals
List of Tables
 Table 1. Global Amphotericin B for Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Amphotericin B for Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Amphotericin B for Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Amphotericin B for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Amphotericin B for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Amphotericin B for Injection Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Amphotericin B for Injection Sales by Region (2020-2025) & (K Units)
 Table 8. Global Amphotericin B for Injection Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Amphotericin B for Injection Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Amphotericin B for Injection Sales Share by Manufacturers (2020-2025)
 Table 12. Global Amphotericin B for Injection Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Amphotericin B for Injection Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Amphotericin B for Injection by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amphotericin B for Injection as of 2024)
 Table 16. Global Amphotericin B for Injection Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Amphotericin B for Injection Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Amphotericin B for Injection Manufacturing Base and Headquarters
 Table 19. Global Amphotericin B for Injection Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Amphotericin B for Injection Sales by Type (2020-2025) & (K Units)
 Table 23. Global Amphotericin B for Injection Sales by Type (2026-2031) & (K Units)
 Table 24. Global Amphotericin B for Injection Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Amphotericin B for Injection Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Amphotericin B for Injection ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Amphotericin B for Injection Sales by Application (2020-2025) & (K Units)
 Table 29. Global Amphotericin B for Injection Sales by Application (2026-2031) & (K Units)
 Table 30. Amphotericin B for Injection High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Amphotericin B for Injection Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Amphotericin B for Injection Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Amphotericin B for Injection ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Amphotericin B for Injection Growth Accelerators and Market Barriers
 Table 37. North America Amphotericin B for Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Amphotericin B for Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Amphotericin B for Injection Growth Accelerators and Market Barriers
 Table 40. Europe Amphotericin B for Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Amphotericin B for Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Amphotericin B for Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Amphotericin B for Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Amphotericin B for Injection Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Amphotericin B for Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Amphotericin B for Injection Investment Opportunities and Key Challenges
 Table 47. Central and South America Amphotericin B for Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Amphotericin B for Injection Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Amphotericin B for Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Gilead Sciences Corporation Information
 Table 51. Gilead Sciences Description and Major Businesses
 Table 52. Gilead Sciences Product Models, Descriptions and Specifications
 Table 53. Gilead Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Gilead Sciences Sales Value Proportion by Product in 2024
 Table 55. Gilead Sciences Sales Value Proportion by Application in 2024
 Table 56. Gilead Sciences Sales Value Proportion by Geographic Area in 2024
 Table 57. Gilead Sciences Amphotericin B for Injection SWOT Analysis
 Table 58. Gilead Sciences Recent Developments
 Table 59. SPH New Asia Pharmaceuticals Corporation Information
 Table 60. SPH New Asia Pharmaceuticals Description and Major Businesses
 Table 61. SPH New Asia Pharmaceuticals Product Models, Descriptions and Specifications
 Table 62. SPH New Asia Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. SPH New Asia Pharmaceuticals Sales Value Proportion by Product in 2024
 Table 64. SPH New Asia Pharmaceuticals Sales Value Proportion by Application in 2024
 Table 65. SPH New Asia Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
 Table 66. SPH New Asia Pharmaceuticals Amphotericin B for Injection SWOT Analysis
 Table 67. SPH New Asia Pharmaceuticals Recent Developments
 Table 68. North China Pharmaceutical Corporation Information
 Table 69. North China Pharmaceutical Description and Major Businesses
 Table 70. North China Pharmaceutical Product Models, Descriptions and Specifications
 Table 71. North China Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. North China Pharmaceutical Sales Value Proportion by Product in 2024
 Table 73. North China Pharmaceutical Sales Value Proportion by Application in 2024
 Table 74. North China Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 75. North China Pharmaceutical Amphotericin B for Injection SWOT Analysis
 Table 76. North China Pharmaceutical Recent Developments
 Table 77. Cspc Holdings Corporation Information
 Table 78. Cspc Holdings Description and Major Businesses
 Table 79. Cspc Holdings Product Models, Descriptions and Specifications
 Table 80. Cspc Holdings Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Cspc Holdings Sales Value Proportion by Product in 2024
 Table 82. Cspc Holdings Sales Value Proportion by Application in 2024
 Table 83. Cspc Holdings Sales Value Proportion by Geographic Area in 2024
 Table 84. Cspc Holdings Amphotericin B for Injection SWOT Analysis
 Table 85. Cspc Holdings Recent Developments
 Table 86. Jemincare Corporation Information
 Table 87. Jemincare Description and Major Businesses
 Table 88. Jemincare Product Models, Descriptions and Specifications
 Table 89. Jemincare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Jemincare Sales Value Proportion by Product in 2024
 Table 91. Jemincare Sales Value Proportion by Application in 2024
 Table 92. Jemincare Sales Value Proportion by Geographic Area in 2024
 Table 93. Jemincare Amphotericin B for Injection SWOT Analysis
 Table 94. Jemincare Recent Developments
 Table 95. Key Raw Materials Distribution
 Table 96. Raw Materials Key Suppliers
 Table 97. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 98. Milestones in Production Technology Evolution
 Table 99. Distributors List
 Table 100. Market Trends and Market Evolution
 Table 101. Market Drivers and Opportunities
 Table 102. Market Challenges, Risks, and Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources


List of Figures
 Figure 1. Amphotericin B for Injection Product Picture
 Figure 2. Global Amphotericin B for Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Common Formulation Product Picture
 Figure 4. Liposome Formulation Product Picture
 Figure 5. Global Amphotericin B for Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Clinic
 Figure 8. Others
 Figure 9. Amphotericin B for Injection Report Years Considered
 Figure 10. Global Amphotericin B for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Amphotericin B for Injection Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Amphotericin B for Injection Revenue Market Share by Region (2020-2031)
 Figure 14. Global Amphotericin B for Injection Sales (2020-2031) & (K Units)
 Figure 15. Global Amphotericin B for Injection Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Amphotericin B for Injection Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Amphotericin B for Injection Sales Volume Market Share in 2024
 Figure 18. Global Amphotericin B for Injection Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Common Formulation Revenue Market Share by Manufacturer in 2024
 Figure 21. Liposome Formulation Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Amphotericin B for Injection Sales Market Share by Type (2020-2031)
 Figure 23. Global Amphotericin B for Injection Revenue Market Share by Type (2020-2031)
 Figure 24. Global Amphotericin B for Injection Sales Market Share by Application (2020-2031)
 Figure 25. Global Amphotericin B for Injection Revenue Market Share by Application (2020-2031)
 Figure 26. North America Amphotericin B for Injection Sales YoY (2020-2031) & (K Units)
 Figure 27. North America Amphotericin B for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Amphotericin B for Injection Sales Revenue (US$ Million) in 2024
 Figure 29. North America Amphotericin B for Injection Sales Volume (K Units) by Type (2020- 2031)
 Figure 30. North America Amphotericin B for Injection Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Amphotericin B for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 32. North America Amphotericin B for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Amphotericin B for Injection Sales YoY (2020-2031) & (K Units)
 Figure 37. Europe Amphotericin B for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Amphotericin B for Injection Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Amphotericin B for Injection Sales Volume (K Units) by Type (2020-2031)
 Figure 40. Europe Amphotericin B for Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Amphotericin B for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 42. Europe Amphotericin B for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 44. France Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Amphotericin B for Injection Sales YoY (2020-2031) & (K Units)
 Figure 49. Asia-Pacific Amphotericin B for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Amphotericin B for Injection Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Amphotericin B for Injection Sales Volume (K Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific Amphotericin B for Injection Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Amphotericin B for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 54. Asia-Pacific Amphotericin B for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 59. India Amphotericin B for Injection Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Amphotericin B for Injection Sales YoY (2020-2031) & (K Units)
 Figure 61. Central and South America Amphotericin B for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Amphotericin B for Injection Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Amphotericin B for Injection Sales Volume (K Units) by Type (2021-2031)
 Figure 64. Central and South America Amphotericin B for Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Amphotericin B for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 66. Central and South America Amphotericin B for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Amphotericin B for Injection Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Amphotericin B for Injection Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Amphotericin B for Injection Sales YoY (2020-2031) & (K Units)
 Figure 70. Middle East and Africa Amphotericin B for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Amphotericin B for Injection Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Amphotericin B for Injection Sales Volume (K Units) by Type (2021-2031)
 Figure 73. South America Amphotericin B for Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Amphotericin B for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 75. Middle East and Africa Amphotericin B for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Amphotericin B for Injection Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Amphotericin B for Injection Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Amphotericin B for Injection Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Amphotericin B for Injection Revenue (2020-2025) & (US$ Million)
 Figure 80. Amphotericin B for Injection Industry Chain Mapping
 Figure 81. Regional Amphotericin B for Injection Manufacturing Base Distribution (%)
 Figure 82. Global Amphotericin B for Injection Production Market Share by Region (2020-2031)
 Figure 83. Amphotericin B for Injection Production Process
 Figure 84. Regional Amphotericin B for Injection Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Amphotericin B Liposome for Injection Market Research Report 2024
Liposomal Amphoteracin B Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AmBisome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mucormycosis Treatment Drugs Market Research Report 2025
Global Amphotericin B Market Research Report 2024
Antifungal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Antifungal Agent Market Research Report 2025
Global Azole Antifungals Market Research Report 2024
Global Antimycotic Medication Market Insights Forecast to 2030
Global Anti fungal Drugs Market Insights Forecast to 2030
5 Fluocytosine Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Amphotericin B API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Fungal Agents Market Insights Forecast to 2030
Global Isavuconazole Sulfate for Injection Market Research Report 2024
Global Anidulafungin for Injection Market Research Report 2024
Blastomycosis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Echinocandins for Injection Market Research Report 2024
Candida Infections Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fungal Keratitis Medicine Market Research Report 2024
Global Posaconazole Market Research Report 2024

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions